A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus.
A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus.
复制标题
DOI:
10.1016/j.semarthrit.2016.01.004
复制
发表时间:
2016-06
影响因子:
5
通讯作者:
Bartels CM
中科院分区:
文献类型:
--
作者:
Medlin JL;Hansen KE;Fitz SR;Bartels CM
Although systemic lupus erythematosus (SLE) most commonly occurs in reproductive-age women, some are diagnosed after age 50. Recognizing that greater than one third of SLE criteria are cutaneous, we undertook a systematic review and meta-analysis to evaluate differences in cutaneous manifestations in early and late-onset SLE patients. We searched the literature using PubMed, CINAHL, Web of Science and Cochrane Library. We excluded studies that did not include ACR SLE classification criteria, early-onset controls, that defined late-onset SLE as <50 years of age, or were not written in English. Two authors rated study quality using the Newcastle Ottawa Quality Scale. We used Forest plots to compare odds ratios (95% confidence intervals) of cutaneous manifestations by age. Study heterogeneity was assessed using I2. Thirty five studies, representing 11,189 early-onset and 1,727 late-onset patients with SLE, met eligibility criteria. The female: male ratio was lower in the late-onset group (5:1 versus 8:1). Most cutaneous manifestations were less prevalent in the late-onset group. In particular, malar rash (OR 0.43 (0.35, 0.52)), photosensitivity (OR 0.72 (0.59, 0.88)) and livedo reticularis (OR 0.33 (0.17, 0.64)) were less common in late-onset patients. In contrast, sicca symptoms were more common (OR 2.45 (1.91, 3.14)). The mean Newcastle Ottawa Quality Scale score was 6.3 ±0.5 (scale 0–9) with high inter-rater reliability for the score (0.96). Overall, cutaneous manifestations are less common in late-onset SLE patients, except sicca symptoms. Future studies should investigate etiologies for this phenomenon including roles of immune senescence, environment, gender and immunogenetics.